Exscientia Ltd ADR (EXAI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.84 +0.15 (+3.20%) 11/19/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.84 unch (unch) -
for Tue, Nov 19th, 2024
Results
download Want to compare other data? Select Fields| Symbol | EXAI | KALV | BVS | ||
| Company | Exscientia Ltd ADR | Kalvista Pharmaceuticals Inc | Bioventus Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.63 | 13.08 | 7.41 | ||
| High | 4.85 | 13.40 | 7.62 | ||
| Low | 4.49 | 12.78 | 7.34 | ||
| Last | 4.84 | 13.08 | 7.56 | ||
| Change | +0.15 | +0.08 | +0.13 | ||
| % Change | +3.20% | +0.62% | +1.75% | ||
| Volume | 1,510,000 | 413,700 | 493,000 | ||
| 20-Day Average Volume | 828,720 | 665,270 | 353,555 | ||
| Previous Close | 4.69 | 13.00 | 7.43 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.15 | 11.77 | 7.97 | ||
| 20-Day Raw Stochastic | 19.12% | 92.33% | 17.70% | ||
| 20-Day Relative Strength | 45.86% | 61.93% | 38.40% | ||
| Weighted Alpha | -23.84 | +18.44 | +25.06 | ||
| Today's Opinion | 80% Sell | 88% Buy | 100% Sell | ||
| Previous Opinion | 72% Sell | 88% Buy | 100% Sell | ||
| Last Month's Opinion | 64% Sell | 56% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.84% since 11/12/24 | +6.34% since 04/22/25 | +0.93% since 04/22/25 | ||
| Low | 4.45 on 11/18/24 | 12.10 on 04/23/25 | 7.34 on 04/29/25 | ||
| High | 6.15 on 11/13/24 | 13.40 on 04/29/25 | 7.98 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -7.10% since 10/18/24 | +9.64% since 03/28/25 | -16.28% since 03/28/25 | ||
| Low | 4.45 on 11/18/24 | 9.23 on 04/09/25 | 7.13 on 04/11/25 | ||
| High | 6.49 on 11/11/24 | 13.40 on 04/29/25 | 9.56 on 04/02/25 | ||
| 3-Month | |||||
| %Chg | -11.84% since 08/19/24 | +49.14% since 01/29/25 | -27.93% since 01/29/25 | ||
| Low | 4.45 on 11/18/24 | 8.67 on 01/31/25 | 7.13 on 04/11/25 | ||
| High | 6.49 on 11/11/24 | 13.40 on 04/29/25 | 11.25 on 03/11/25 | ||
| 6-Month | |||||
| %Chg | -6.92% since 05/17/24 | +10.94% since 10/29/24 | -43.20% since 10/29/24 | ||
| Low | 3.80 on 08/05/24 | 7.30 on 01/13/25 | 7.13 on 04/11/25 | ||
| High | 6.49 on 11/11/24 | 13.40 on 04/29/25 | 14.38 on 11/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 632,927 | 646,308 | 608,844 | ||
| Shares Outstanding, K | 130,770 | 49,716 | 81,944 | ||
| Annual Sales | 24,980,000 | 0 | 573,280,000 | ||
| Annual Net Income | -181,560,000 | -126,640,000 | -33,540,000 | ||
| Last Quarter Sales | 6,410,000 | 0 | 153,640,000 | ||
| Last Quarter Net Income | -67,800,000 | -48,510,000 | -160,000 | ||
| 60-Month Beta | 0.83 | 0.39 | 0.92 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.52 on 11/08/24 | -0.92 on 03/12/25 | 0.15 on 03/11/25 | ||
| Latest Earnings Date | 11/14/24 | 03/10/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 16.28 | ||